Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined

Zero risk tolerance costs lives: loss of transplantable organs due to human immunodeficiency virus nucleic acid testing of potential donors

(2015) Teresa Shafer et al.   Progress in Transplantation

Review and management of drug interactions with boceprevir and telaprevir

(2012) Jennifer J. Kiser et al.   HEPATOLOGY

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

(2011) Varun Garg et al.   HEPATOLOGY

8 EVOLUTION OF TREATMENT-EMERGENT RESISTANT VARIANTS IN TELAPREVIR PHASE 3 CLINICAL TRIALS

(2011) J.C. Sullivan et al.   JOURNAL OF HEPATOLOGY

Boceprevir for Chronic HCV Genotype 1 Infection

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Retreatment of HCV Infection

(2011) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Follow-Up and Outcome of Liver Transplantation From Anti-Hepatitis C Virus-Positive Donors: A European Multicentric Case-Control Study

(2011) Roberto Ballarin et al.   TRANSPLANTATION

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

(2010) Michael R. Charlton et al.   HEPATOLOGY

Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid

(2010) Stephen R. Lee et al.   JOURNAL OF VIROLOGICAL METHODS